Global Coronary Stents Market (Bare Metal, Drug-Eluting ...€¦ · Global Coronary Stents Market...

19
(c) AZOTH Analytics November 2016 Global Coronary Stents Market (Bare Metal, Drug-Eluting, Bioresorable): Analysis By Segment, By Region, By Country (2016-2021) By Segment - Bare Metal stents (BMS), Drug-Eluting Stents (DES), Bioresorbable Stents; By Region - North America, Europe, APAC, ROW; By Country - USA, Canada, UK, Germany, India, Japan, China, Brazil, UAE Market Entry Strategies for Global Players Coronary Stents - Pipeline Analysis

Transcript of Global Coronary Stents Market (Bare Metal, Drug-Eluting ...€¦ · Global Coronary Stents Market...

(c) AZOTH Analytics November 2016

Global Coronary Stents Market (Bare Metal, Drug-Eluting,

Bioresorable): Analysis By Segment, By Region, By Country

(2016-2021)

• By Segment - Bare Metal stents (BMS),

Drug-Eluting Stents (DES), Bioresorbable

Stents;

• By Region - North America, Europe, APAC,

ROW;

• By Country - USA, Canada, UK, Germany,

India, Japan, China, Brazil, UAE

• Market Entry Strategies for Global Players

• Coronary Stents - Pipeline Analysis

(c) AZOTH Analytics

Table of Contents

2

S.No Particulars Page No.

1. Research Methodology 15

2. Executive Summary 16

3. Strategic Recommendations

3.1. Bioresorbable Stents as the Future Market 18

3.2. Focus on Lowering of ASP in Coronary Stents 19

3.3. Opportunities in APAC Region 20

4. Global Coronary Stents Market: An Overview

4.1. Product Overview 21

4.2. Global Coronary Stents Market 27

4.2.1. By Value (Historic 2011-15) 28

4.2.2. By Value ( Forecast 2016E-2021F) 28

4.3. Global Coronary Stent Market, By Segments 31

4.3.1. In Percentage (2015) 31

4.3.2. In Percentage (2021F) 31

4.4. Global Bare Metal Stents, By Value 32

4.4.1. By Value (Historic 2011-15) 32

4.4.2. By Value ( Forecast 2016E-2021F) 32

4.5. Global Drug Eluting Stents, By Value 33

(c) AZOTH Analytics

Table of Contents

3

S. No Particulars Page No.

4.5.1. By Value (Historic 2011-15) 33

4.5.2. By Value ( Forecast 2016E-2021F) 33

4.6. Global Bioresorbable Stents Market, By Segments 34

4.6.1. By Value (Historic 2011-15) 34

4.6.2. By Value ( Forecast 2016E-2021F) 34

4.7. Global Coronary Stent Market, By Region 35

4.7.1. In Percentage (2015) 35

4.7.2. In Percentage (2021F) 35

4.8. Coronary Stents : Pipeline Analysis 36

5. North America Coronary Stent Market: An Overview 44

5.1. North America Coronary Stent Market , By Value 45

5.1.1. By Value (Historic 2011-15) 45

5.1.2. By Value ( Forecast 2016E-2021F) 45

5.2. North America Bare Metal Stent Market , By Value 49

5.2.1. By Value (Historic 2011-15) 49

5.2.2. By Value ( Forecast 2016E-2021F) 49

5.3. North America Drug Eluting Stent Market , By Value 50

5.3.1. By Value (Historic 2011-15) 50

5.3.2. By Value ( Forecast 2016E-2021F) 50

5.4. North America Bioresorbable Stent Market , By Value 51

(c) AZOTH Analytics

Table of Contents

S. No Particulars Page No.

5.4.1. By Value ( 2011-2021F) 51

5.5. North America Coronary Stent Market, By Country , By Percentage 52

5.5.1. In Percentage (2015) 52

5.5.2. In Percentage (2021F) 52

5.6. North America Coronary Stent Market, By Country (USA, Canada) (2011-2021F) 53

5.5.1. USA Coronary Stents Market, By Value 54

5.5.1.1. By Value ( 2011-2021F) 54

5.5.1. Canada Coronary Stents Market, By Value 59

5.5.1.1. By Value ( 2011-2021F) 59

6. Europe Coronary Stent Market: An Overview 61

6.1. Europe Coronary Stent Market , By Value 62

6.1.1. By Value (Historic 2011-15) 62

6.1.2. By Value ( Forecast 2016E-2021F) 62

6.2. Europe Bare Metal Stent Market , By Value 65

6.2.1. By Value (Historic 2011-15) 65

6.2.2. By Value ( Forecast 2016E-2021F) 65

6.3. Europe Drug Eluting Stent Market , By Value 66

6.3.1. By Value (Historic 2011-15) 66

6.3.2. By Value ( Forecast 2016E-2021F) 66

4

(c) AZOTH Analytics

Table of Contents

S. No Particulars Page No.

6.4. Europe Bioresorbable Stent Market , By Value 67

6.4.1 By Value (Historic 2012-15) 67

6.4.2. By Value ( Forecast 2016E-2021F) 67

6.5. Europe Coronary Stent Market, By Country , By Percentage 68

6.5.1. In Percentage (2015) 68

6.5.2. In Percentage (2021F) 68

6.6. Europe Coronary Stent Market, By Country (UK, Germany(2011-2021F) 69

6.6.1. UK Coronary Stents Market, By Value 70

6.6.1.1. By Value ( 2011-2021F) 70

6.6.2. Germany Coronary Stents Market, By Value 73

6.6.2.1. By Value ( 2011-2021F) 73

7. APAC Coronary Stent Market: An Overview 76

7.1. APAC Coronary Stent Market , By Value 77

7.1.1. By Value (Historic 2011-15) 77

7.1.2. By Value ( Forecast 2016E-2021F) 77

7.2. APAC Bare Metal Stent Market , By Value 80

7.2.1. By Value (Historic 2011-15) 80

7.2.2. By Value ( Forecast 2016E-2021F) 80

7.3. APAC Drug Eluting Stent Market , By Value 81

7.3.1. By Value (Historic 2011-15) 81

5

(c) AZOTH Analytics

Table of Contents

S. No Particulars Page No.

7.3.2. By Value ( Forecast 2016E-2021F) 81

7.4. APAC Bioresorbable Stent Market , By Value 82

7.4.1. By Value ( Forecast 2011-2021F) 82

7.5. APAC Coronary Stent Market, By Country , By Percentage 83

7.5.1. In Percentage (2015) 83

7.5.2. In Percentage (2021F) 83

7.6. APAC Coronary Stent Market, By Country (China, Japan, India(2011-2021F) 84

7.6.1. China Coronary Stents Market, By Value 85

7.6.1.1. By Value ( 2011-2021F) 85

7.6.2. Japan Coronary Stents Market, By Value 88

7.6.2.1. By Value ( 2011-2021F) 88

7.6.3. India Coronary Stents Market, By Value 91

7.6.3.1. By Value ( 2011-2021F) 91

8. ROW Coronary Stent Market: An Overview 94

8.1. ROW Coronary Stent Market , By Value 95

8.1.1. By Value (Historic 2011-15) 95

8.1.2. By Value ( Forecast 2016E-2021F) 95

8.2. ROW Bare Metal Stent Market , By Value 98

8.2.1. By Value (Historic 2011-15) 98

8.2.2. By Value ( Forecast 2016E-2021F) 98

6

(c) AZOTH Analytics

Table of Contents

S. No Particulars Page No.

8.3. ROW Drug Eluting Stent Market , By Value 99

8.3.1. By Value (Historic 2011-15) 99

8.3.2. By Value ( Forecast 2016E-2021F) 99

8.4. ROW Bioresorbable Stent Market , By Value 100

8.4.1. By Value ( Forecast 2012-2021F) 100

8.5. ROW Coronary Stent Market, By Country , By Percentage 101

8.5.1. In Percentage (2015) 101

8.5.2. In Percentage (2021F) 101

8.6. ROW Coronary Stent Market, By Country (Brazil, UAE) (2011-2021F) 102

Brazil Coronary Stents Market, By Value 102

8.6.1.1. By Value ( 2011-2021F) 102

UAE Coronary Stents Market, By Value 104

8.6.2.1. By Value ( 2011-2021F) 104

9. Market Dynamics

9.1. Trends 108

9.2. Drivers 114

9.3. Challenges 118

10. Pricing Structure 120

7

(c) AZOTH Analytics

Table of Contents

S. No Particulars Page No.

11. Policy and Regulatory Land scape 123

12. M&A and Licensing Route to the Coronary Stents Market 129

13. SWOT Analysis 136

14. Porter Five Force Model 137

15. Product Benchmarking 140

16. Company Profiling 141

16.1. Terumo Corporation 142

16.2. Boston Scientific 145

16.3. Stentys SA 147

16.4. MicroPort Scientific Corporation 148

16.5. Biotronik 150

16.6. Elixir Medical Corporation 151

16.7. Biosensors Inc. 152

16.8. Medtronic 153

16.9. Abbott Laboratories 155

16.10. Kyoto Medical Planning 157

17. About Us and Disclaimer 158

8

(c) AZOTH Analytics

List of Figures

Figure No. Figure Title Page No.

Figure 1: Global Coronary Stent Market Size, By Value, 2011-2021F (USD Billion) 28

Figure 2: Number of Annual Deaths Due to Cardiovascular Diseases 29

Figure 3: Life and Non Life Insurance Penetration in Select Countries 2015 in Percentage 30

Figure 4: Global Coronary Stent Market Segment Share 2015 In Percentage 31

Figure 5: Global Coronary Stent Market Segment Share 2021 In Percentage 31

Figure 6: Global Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Billion 32

Figure 7: Global Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Billion 32

Figure 8: Global Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion 33

Figure 9: Global Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion 33

Figure 10: Global Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million 34

Figure 11: Global Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 34

Figure 12: Global Coronary Stent Market Region Share 2015 In Percentage 35

Figure 13: Global Coronary Stent Market Region Share 2021 In Percentage 35

Figure 14: North America Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion 45

Figure 15: North America Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion 45

Figure 16: Payment for Cardiology Services in USA 48

Figure 17: North America Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million 49

Figure 18: North America Bare Metal Stent Market By Value , Forecast(2016E-2021F) in USD Million 49

Figure 19: North America Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion 50

9

(c) AZOTH Analytics

List of Figures

Figure No. Figure Title Page No.

Figure 20: North America Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion 50

Figure 21: North America Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 51

Figure 22: North America Coronary Stent Market, By Country – 2015(%) 52

Figure 23: North America Coronary Stent Market, By Country – 2021F(%) 52

Figure 24: USA Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion 54

Figure 25: USA Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion 54

Figure 26: Percentage of Population Suffering From Cardiovascular Disease in USA (2009-2012) 56

Figure 27: Direct and Indirect Costs Associated With Major Heart Diseases in USA (USD Billion) (2009-2012) 56

Figure 28: Canada Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 59

Figure 29: Canada Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 59

Figure 30: Europe Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion 62

Figure 31: Europe Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion 62

Figure 32: Cost of CVD in 2014 in some European Countries 63

Figure 33: Europe Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million 65

Figure 34: Europe Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Million 65

Figure 35: Europe Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion 66

Figure 36: Europe Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion 66

Figure 37: Europe Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million 67

Figure 38: Europe Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 67

Figure 39: Europe Coronary Stent Market, By Country – 2015(%) 68

Figure 40: Europe Coronary Stent Market, By Country – 2021F(%) 68

10

(c) AZOTH Analytics

List of Figures

Figure No. Figure Title Page No.

Figure 41: UK Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 70

Figure 42: UK Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 70

Figure 43: Germany Coronary Stents Market, By Value , Historic(2011-2015) in USD Million 73

Figure 44: Germany Coronary Stents Market By Value , Forecast(2016E-2021F) in USD Million 73

Figure 45: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 75

Figure 46: Others Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 75

Figure 47: APAC Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion 77

Figure 48: APAC Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion 77

Figure 49: APAC Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million 80

Figure 50: APAC Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Million 80

Figure 51: APAC Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Million 81

Figure 52: APAC Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Million 81

Figure 53: APAC Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million 82

Figure 54: APAC Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 82

Figure 55: APAC Coronary Stent Market, By Country – 2015(%) 83

Figure 56: APAC Coronary Stent Market, By Country – 2021F(%) 83

Figure 57: China Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 85

Figure 58: China Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 85

Figure 59: Japan Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 88

Figure 60: Japan Coronary Market By Value , Forecast(2016E-2021F) in USD Million 88

11

(c) AZOTH Analytics

List of Figures

Figure No. Figure Title Page No.

Figure 61: India Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 91

Figure 62: India Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 91

Figure 63: ROW Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 93

Figure 64: ROW Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 93

Figure 65: ROW Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 95

Figure 66: ROW Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 95

Figure 67: ROW Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million 98

Figure 68: ROW Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Million 98

Figure 69: ROW Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion 99

Figure 70: ROW Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion 99

Figure 71: ROW Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million 100

Figure 72: ROW Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 100

Figure 73: ROW Coronary Stent Market, By Country – 2015(%) 101

Figure 74: ROW Coronary Stent Market, By Country – 2021F(%) 101

Figure 75: Brazil Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 102

Figure 76: Brazil Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 102

Figure 77: UAE Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 104

Figure 78: UAE Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 104

Figure 79: Causes of Death in UAE 105

Figure 80: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 106

12

(c) AZOTH Analytics

List of Figures and Tables

Figure No. Figure Title Page No.

Figure 81: Others Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 106

Figure 82: Average Price of Bare-metal stents 121

Figure 83: Average Price of Drug Eluting stents 122

Figure 84: Cardiac And Vascular Business, By Segment-2015 143

Figure 85: Cardiac And Vascular Business, By Geography - 2015 143

Figure 86: Revenue, By Segment-2015 (in Percentage) 146

Figure 87: Revenue, By Geography - 2015 146

Figure 88: Revenue, By Segment-2015 (in Percentage) 149

Figure 89: Revenue, By Geography - 2015 149

Figure 90: Revenue, By Segment-2015 (in Percentage) 154

Figure 91: Cardiac and Vascular Group Revenue, By Geography - 2015 154

Figure 92: Revenue, By Segment-2015 (in Percentage) 156

Figure 93: Overall Revenue, By Geography - 2015 156

13

Table No. Table Title Page No.

Table 1: Number of Physicians in Cardiology in Canada in 2016 60

Table 2: Average Price of Bare-metal stents 121

Table 3: Average Price of Drug Eluting stents 122

Table 4: Cardio and Vascular Business Revenue By Segment (in USD Billion) 144

(c) AZOTH Analytics 14

Coronary Stents Market (2011-15)

Coronary Stents Market (2016-21)

Breakdown-By Stent Type

Bare Metal Stent Market (2011-15)

Bare Metal Stent Market (2016-21)

Drug Eluting Market (2011-2015)

Drug Eluting Market (2016-2021)

Bioresorbable Stent Market (2011-2015)

Bioresorbable Stent Market (2016-2021)

Global Coverage Regional Coverage

Global Coronary Stents Market - Stent Type (Bare Metal Stent, Drug Eluting Stent, Bioresorbable Stent):

Analysis By Region, By Country (2016-2021)

Coronary Stents Market (2011-15) Coronary Stents Market (2016-21) Coronary Stents Market : By Stent

Type (2011-15) Coronary Stents Market : By Stent

Type (2016-21)

North America Europe Asia Pacific ROW

Country Coverage

Coronary Stents Market (2011-15)

Coronary Stents Market (2016-21)

U.S. Canada U.K. Germany China Japan India Brazil UAE

Company Coverage

Product Benchmarking Policy and Regulatory

Landscape Financial Analysis

Sales Business Strategy Market Entry Strategy

Boston Scientific Stentys Terumo Microport Biotronik Abbott Medtronic Elixir Medical Kyoto Medical Planning Biosensors Inc.

Global Coverage Regional Coverage Country Coverage

Scope of the Study

Segment Coverage Stent Type (Bare Metal Stent, Drug

Eluting Stent, Bioresorbable Stent)

Market Trends Company Analysis

(c) AZOTH Analytics

Research Methodology

Research Definition

• The present report presents the in depth study of global coronary stent market. The market has been segmented by

bare metal stents, drug eluting stents and bioresorbable stents. Regional Analysis consists of four major regions-

North America, Europe, Asia-pacific , and Rest of the world including countries – U.S., Canada, Germany , France ,

China, India, Japan ,Brazil etc.

Data Analysis and Interpretation

• Our historic market trend has been figured out by various paid databases which was further triangulated with inputs

and insights from industry experts, companies and stakeholders, through primary research (marketing managers,

BDE, Zonal Managers). Back-of-the-Envelope calculation for the market estimation has been made through proper

understanding of the market as well as future business strategies of the companies operating in the market.

Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market

segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive primary surveys by

reaching out industry experts across the value chain of the global coronary stent market

For Forecasting purpose we have accessed some of the paid databases such as Bloomberg, Reuters, Factiva, Hoovers etc.

Companies Contacted Abbott Laboratories, Medtronic, Biotronik, Boston Scientific, Terumo Corporation

15

(c) AZOTH Analytics

Global Bare Metal Stent Market , By Value

16

2011 2012 2013 2014 20152016 2017 2018 2019 2020 2021

CAGR: x% CAGR: x%

Figure 6 : Global Bare Metal Stent Market, By Value ,

Historic(2011-2015) in USD Billion

Figure 7 : Global Bare Metal Stent Market, By Value ,

Forecast(2016E-2021F) in USD Billion

• Bare Metal stents have been witnessing decline over the years considering the stent metal have been used for scaffolding purpose

and widen the gap between the coronary arteries. However, the metal used was known to cause inflammation. Also, these stents had

a high rate of restenosis, which led to frequent re-stenting procedures. With the adoption of DES, these stents have been slowly

shifting towards lesser growth. However, they are still prominent as they are economically priced or used on patients who are

ineligible for DES.

Source: Azoth Analytics

(c) AZOTH Analytics

Global Drug Eluting Stent Market , By Value

17

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

CAGR: x% CAGR: x%

Figure 8 : Global Drug Eluting Stent Market, By Value ,

Historic(2011-2015) in USD Billion

Figure 9 : Global Drug Eluting Stent Market By

Value , Forecast(2016E-2021F) in USD Billion

• Market for DES is highly dominating as they constituted of the drugs that reduced or delayed the need for restenosis, and prevented

the need for re-stenting. Thus, these stents have gained traction over the years, and acceptance by medical associations and

cardiologists supported the demand for DES. Overtime, they have been shifted to biodegradable polymer. However, while they were

effective in delay of restonisis, they were known to cause late thrombosis, as well as vasomotion. The market is expected to remain

stable in the forecast period, due to their high adoption.

Source: Azoth Analytics

(c) AZOTH Analytics

Global Bioresorbable Stent Market , By Value

18

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

CAGR: x% CAGR: x%

Figure 10 : Global Bioresorbable Stent Market, By

Value , Historic(2011-2015) in USD Million

Figure 11 : Global Bioresorbable Stent Market By

Value , Forecast(2016E-2021F) in USD Million

• Bioresorbable stents are known to dissolve completely within the body in short span of 2-3 years. Technological innovation and

growing compatibility through clinical trials has led to the high demand for bioresorbable stents. The market is expected to witness

tremendous growth in the forecast period on the back of FDA approval of these stents in USA, leading to a high demand for stent

procedures using these stents.

Source: Azoth Analytics

(c) AZOTH Analytics

About Azoth Analytics Pvt Ltd.

Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary

research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and

industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and

local clients. We provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and

gas, retail, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors .

Related Reports:

Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics

therefore, takes no responsibility for any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does

not warranty the completeness of the information and data. Also, analysis provided in the report are meant for customers’ internal use

only and not for general publication or disclosure to third parties.

19